Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion.
This study reports that plasma neurofilament light chain is elevated in isolated REM sleep behavior disorder, correlates with neurogenic orthostatic hypotension, and may mark an autonomic-severe iRBD subgroup with greater risk of phenoconversion (notably to MSA).
What the AI sees
This study reports that plasma neurofilament light chain is elevated in isolated REM sleep behavior disorder, correlates with neurogenic orthostatic hypotension, and may mark an autonomic-severe iRBD subgroup with greater risk of phenoconversion (notably to MSA).
Research significance
As a noninvasive biomarker linked to autonomic dysfunction and conversion risk, plasma NfL could be used to stratify prodromal cohorts and enrich clinical trials for patients most likely to progress, aiding therapeutic development and trial design.
Source abstract
BackgroundIsolated REM sleep behavior disorder (iRBD) is a prodromal stage of α-synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Evaluating trajectories of phenoconversion is crucial in this population. Plasma neurofilament light chain (NfL), a marker of axonal injury, has emerged as a promising candidate for tracking disease progression.ObjectivesTo assess plasma NfL levels in iRBD patients, examine their associations with clinical features, particularly neurogenic orthostatic hypotension (nOH), and explore their potential role in predicting phenoconversion.MethodsPlasma NfL was measured in 54 iRBD subjects, 54 PD, 54 healthy controls and 16 MSA. Participants underwent motor, cognitive, and non-motor symptoms assessments. Longitudinal follow-up data have been collected for iRBD subjects. NfL was quantified using the Ella platform; analyses were performed with Prism 9.ResultsNfL levels were significantly higher in iRBD compared to controls and similar to PD. iRBD-nOH+ patients had significantly higher NfL than nOH- counterparts, with values overlapping PD and MSA. nOH was inversely associated with hyposmia, supporting phenotypic divergence. NfL correlated positively with SCOPA-AUT and BDI scores. At follow-up, all four MSA converters had nOH at baseline.ConclusionsPlasma NfL elevation in iRBD supports its role as a marker of early neurodegeneration. Its association with nOH suggests that this autonomic feature may identify a biologically more severe iRBD phenotype, possibly on a trajectory toward MSA. These findings warrant extended longitudinal validation and support the integration of clinical and biological markers, including NfL, for stratifying conversion risk.